Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma

The clinical implications of plasmatic cell-free and tumor DNA (cfDNA and ctDNA) are challenging in glioblastoma. This prospective study included 52 consecutive newly diagnosed glioblastoma (n = 49) or gliosarcoma (n = 3) patients treated with concomitant temozolomide and radiotherapy (RT-TMZ), foll...

Descripción completa

Detalles Bibliográficos
Autores principales: Fontanilles, Maxime, Marguet, Florent, Beaussire, Ludivine, Magne, Nicolas, Pépin, Louis-Ferdinand, Alexandru, Cristina, Tennevet, Isabelle, Hanzen, Chantal, Langlois, Olivier, Jardin, Fabrice, Laquerrière, Annie, Sarafan-Vasseur, Nasrin, Di Fiore, Fréderic, Clatot, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641818/
https://www.ncbi.nlm.nih.gov/pubmed/33148330
http://dx.doi.org/10.1186/s40478-020-01057-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641818/
https://www.ncbi.nlm.nih.gov/pubmed/33148330
http://dx.doi.org/10.1186/s40478-020-01057-7

Ejemplares similares